Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
NCT05199038
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
184
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Varices
Interventions
DRUG:
Octreotide
Sponsor
Tanta University